430 related articles for article (PubMed ID: 28155189)
1. Diabetes Secondary to Treatment with Statins.
Laakso M; Kuusisto J
Curr Diab Rep; 2017 Feb; 17(2):10. PubMed ID: 28155189
[TBL] [Abstract][Full Text] [Related]
2. Diabetogenic Action of Statins: Mechanisms.
Carmena R; Betteridge DJ
Curr Atheroscler Rep; 2019 Apr; 21(6):23. PubMed ID: 31037345
[TBL] [Abstract][Full Text] [Related]
3. Statins and their increased risk of inducing diabetes.
Agouridis AP; Kostapanos MS; Elisaf MS
Expert Opin Drug Saf; 2015; 14(12):1835-44. PubMed ID: 26437128
[TBL] [Abstract][Full Text] [Related]
4. Statin-associated incident diabetes: a literature review.
Park ZH; Juska A; Dyakov D; Patel RV
Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689
[TBL] [Abstract][Full Text] [Related]
5. The good and bad effects of statins on insulin sensitivity and secretion.
Muscogiuri G; Sarno G; Gastaldelli A; Savastano S; Ascione A; Colao A; Orio F
Endocr Res; 2014; 39(4):137-43. PubMed ID: 25208056
[TBL] [Abstract][Full Text] [Related]
6. Statins and diabetes risk: how real is it and what are the mechanisms?
Robinson JG
Curr Opin Lipidol; 2015 Jun; 26(3):228-35. PubMed ID: 25887679
[TBL] [Abstract][Full Text] [Related]
7. How do we know that statins are diabetogenic, and why? Is it an important issue in the clinical practice?
Cybulska B; Kłosiewicz-Latoszek L
Kardiol Pol; 2018; 76(8):1217-1223. PubMed ID: 30067279
[TBL] [Abstract][Full Text] [Related]
8. Statin diabetogenicity: guidance for clinicians.
Ray K
Cardiovasc Diabetol; 2013; 12 Suppl 1(Suppl 1):S3. PubMed ID: 23819776
[TBL] [Abstract][Full Text] [Related]
9. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
Cziraky MJ; Watson KE; Talbert RL
J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
[TBL] [Abstract][Full Text] [Related]
10. Statin therapy on glycemic control in type 2 diabetic patients: A network meta-analysis.
Cui JY; Zhou RR; Han S; Wang TS; Wang LQ; Xie XH
J Clin Pharm Ther; 2018 Aug; 43(4):556-570. PubMed ID: 29733433
[TBL] [Abstract][Full Text] [Related]
11. Genetic insights into statin-associated diabetes risk.
Swerdlow DI; Preiss D
Curr Opin Lipidol; 2016 Apr; 27(2):125-30. PubMed ID: 26959703
[TBL] [Abstract][Full Text] [Related]
12. The diabetogenic action of statins - mechanisms and clinical implications.
Betteridge DJ; Carmena R
Nat Rev Endocrinol; 2016 Feb; 12(2):99-110. PubMed ID: 26668119
[TBL] [Abstract][Full Text] [Related]
13. Differential metabolic effects of distinct statins.
Koh KK; Sakuma I; Quon MJ
Atherosclerosis; 2011 Mar; 215(1):1-8. PubMed ID: 21130454
[TBL] [Abstract][Full Text] [Related]
14. The use of statins in people at risk of developing diabetes mellitus: evidence and guidance for clinical practice.
Sattar NA; Ginsberg H; Ray K; Chapman MJ; Arca M; Averna M; Betteridge DJ; Bhatnagar D; Bilianou E; Carmena R; Ceška R; Corsini A; Erbel R; Flynn PD; Garcia-Moll X; Gumprecht J; Ishibashi S; Jambart S; Kastelein JJ; Maher V; da Silva PM; Masana L; Odawara M; Pedersen TR; Rotella CM; Salti I; Teramoto T; Tokgozoglu L; Toth PP; Valensi P; Vergès B
Atheroscler Suppl; 2014 Jun; 15(1):1-15. PubMed ID: 24840509
[TBL] [Abstract][Full Text] [Related]
15. New onset diabetes mellitus induced by statins: current evidence.
Chrysant SG
Postgrad Med; 2017 May; 129(4):430-435. PubMed ID: 28276790
[TBL] [Abstract][Full Text] [Related]
16. Statin treatment is associated with insulin sensitivity decrease in type 1 diabetes mellitus: A prospective, observational 56-month follow-up study.
Duvnjak L; Blaslov K
J Clin Lipidol; 2016; 10(4):1004-1010. PubMed ID: 27578133
[TBL] [Abstract][Full Text] [Related]
17. Statin Treatment-Induced Development of Type 2 Diabetes: From Clinical Evidence to Mechanistic Insights.
Galicia-Garcia U; Jebari S; Larrea-Sebal A; Uribe KB; Siddiqi H; Ostolaza H; Benito-Vicente A; Martín C
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630698
[TBL] [Abstract][Full Text] [Related]
18. Statin-Associated Diabetes Mellitus: Review and Clinical Guide.
Backes JM; Kostoff MD; Gibson CA; Ruisinger JF
South Med J; 2016 Mar; 109(3):167-73. PubMed ID: 26954655
[TBL] [Abstract][Full Text] [Related]
19. Effect of statin therapy on incident type 2 diabetes mellitus in patients with clinically manifest vascular disease.
van de Woestijne AP; van der Graaf Y; Westerink J; Nathoe HM; Visseren FL
Am J Cardiol; 2015 Feb; 115(4):441-6. PubMed ID: 25554536
[TBL] [Abstract][Full Text] [Related]
20. Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort.
Cederberg H; Stančáková A; Yaluri N; Modi S; Kuusisto J; Laakso M
Diabetologia; 2015 May; 58(5):1109-17. PubMed ID: 25754552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
